Substance Abuse Disorders Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
Conditions: Alcohol Use Disorder (AUD); Post Traumatic Stress Disorder (PTSD) Interventions: Drug: Placebo; Drug: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg; Drug: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg; Procedure: Ethanol Infusion; Behavioral: PTSD Reactivity Condition; Behavioral: Alcohol Cue R eactivity Sponsors: Pharmacotherapies for Alcohol and Substance Abuse Consortium; United States Department of Defense; Congressionally Directed Medical Research Programs; RTI International; VA Connecticu...
Source: ClinicalTrials.gov - April 1, 2021 Category: Research Source Type: clinical trials

BabySTEPs: Supportive Texts Empowering Parents
Condition: Alcohol Drinking Intervention: Behavioral: TMI Component Sponsors: The National Center on Addiction and Substance Abuse at Columbia University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials